Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Chapman

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Scientific Reports|March 20, 2019
The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritisSadaf Ashraf, Masar Radhi, Peter Gowler, et al.
Obstetrics and Gynecology|January 10, 2012
Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trialAlan T N Tita, Jeff M Szychowski, Dwight J Rouse, et al.
Arthritis Research & Therapy|April 18, 2008
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritisDenise Richardson, Richard G Pearson, Nisha Kurian, et al.
British Journal of Pharmacology|May 19, 2012
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid systemBright N Okine, Leonie M Norris, Stephen Woodhams, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis PainJunting Huang, James J Burston, Li Li, et al.
Pain Reports|February 2, 2019
Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis painLilian N Nwosu, Peter R W Gowler, James J Burston, et al.
Scientific Reports|September 9, 2017
Association of the resolvin precursor 17-HDHA, but not D- or E- series resolvins, with heat pain sensitivity and osteoarthritis pain in humansAna M Valdes, Srinivasarao Ravipati, Cristina Menni, et al.
European Journal of Pediatrics|January 22, 2024
Greater rate of weight loss predicts paediatric hospital admission in adolescent typical and atypical anorexia nervosaCliona Brennan, Erica Cini, Sarah Illingworth, et al.
Pain Reports|February 7, 2022
Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesiaAmanda Lillywhite, Stephen G Woodhams, Sara V Gonçalves, et al.
Neuropharmacology|June 7, 2008
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory painMaulik D Jhaveri, Denise Richardson, Ian Robinson, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Scientific Reports|March 20, 2019
The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritisSadaf Ashraf, Masar Radhi, Peter Gowler, et al.
Obstetrics and Gynecology|January 10, 2012
Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trialAlan T N Tita, Jeff M Szychowski, Dwight J Rouse, et al.
Arthritis Research & Therapy|April 18, 2008
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritisDenise Richardson, Richard G Pearson, Nisha Kurian, et al.
British Journal of Pharmacology|May 19, 2012
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid systemBright N Okine, Leonie M Norris, Stephen Woodhams, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis PainJunting Huang, James J Burston, Li Li, et al.
Pain Reports|February 2, 2019
Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis painLilian N Nwosu, Peter R W Gowler, James J Burston, et al.
Scientific Reports|September 9, 2017
Association of the resolvin precursor 17-HDHA, but not D- or E- series resolvins, with heat pain sensitivity and osteoarthritis pain in humansAna M Valdes, Srinivasarao Ravipati, Cristina Menni, et al.
European Journal of Pediatrics|January 22, 2024
Greater rate of weight loss predicts paediatric hospital admission in adolescent typical and atypical anorexia nervosaCliona Brennan, Erica Cini, Sarah Illingworth, et al.
Pain Reports|February 7, 2022
Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesiaAmanda Lillywhite, Stephen G Woodhams, Sara V Gonçalves, et al.
Neuropharmacology|June 7, 2008
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory painMaulik D Jhaveri, Denise Richardson, Ian Robinson, et al.
Pageof 12